Diabetes mellitus occurs in a significant number of patients following renal transplantation. New‐onset diabetes after transplant (NODAT) is associated with increased mortality and morbidity and, in particular, higher rates of cardiovascular disease and infection, which are the leading causes of death in renal transplant recipients. The study was conducted at Apollo hospital, Chennai from October 2015 to June 2017. All non‐diabetic patients undergoing renal transplant were enrolled in study between October 2015 to December 2016 and these patients were followed till 6 months post‐transplant period last follow‐up, so the 6 month follow‐up for last patient was in June 2017. Twenty seven (54%) patients were having Chronic glomerulonephritis (CGN) as underlying kidney disease, 8 (16%) patients were having Chronic interstitial nephritis (CIN), 6 (12%) patients were having Chronic pyelonephritis (CPN) and 2 (4%) were having Polycystic kidney disease, 6 (12%) were having hypertensive nephrosclerosis and 1 (2%) patient was having hereditery nephropathy as underlying disease. There is significant effect of pre and 1 month post‐transplant GTT, pre‐transplant HbA1c and pre‐transplant serum triglyceride levels on the development of NODAT.
Vijay Maidapwad, Maya lende, Manisha Bhosale and Vinodkumar Mohabe. Study of Incidence of New Onset Diabetes After Transplant (NODAT) in Renal Transplant Recipients in a Hospital.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.5.537.542
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.5.537.542